AbbVie Stock Forecast
| Recent AbbVie Stock Price |
|
AbbVie Stock Forecast Price |
| $161.72 |
+11.07% |
$179.63 |
As of 2024-05-02
| Recent AbbVie Analyst Ratings Breakdown |
| |
Current |
1 Mo. Ago |
2 Mo. Ago |
3 Mo. Ago |
| Strong buy ratings: |
11 |
11 |
11 |
10 |
| Buy ratings: |
2 |
2 |
2 |
2 |
| Hold ratings: |
8 |
8 |
8 |
7 |
| Sell ratings: |
0 |
0 |
0 |
0 |
| Strong sell ratings: |
0 |
0 |
0 |
0 |
| Average rating: |
1.83 |
1.83 |
1.83 |
1.82 |
In the last row of the above table, the average rating presented is from 1 to 5 where 1 means Strong Buy and 5 means Strong Sell.
The presented AbbVie stock forecast (traded under symbol ABBV), for forward-twelve-months price target as shown at the top of this page, gives you the average AbbVie stock forecast for forward target price for symbol ABBV, across the 19 analysts covering AbbVie (ABBV), as reported in
data provided by Zacks Investment Research via Quandl.com.
Investors should also take note that the median AbbVie stock forecast price target (i.e. representing the middle ground number where half of analysts had a higher AbbVie stock forecast and half had a lower AbbVie stock forecast) was $180.0 as of 2024-05-02 (which is a different mathematical metric versus taking the average or mean), while the
highest AbbVie stock forecast in the analyst group was $200.0, and the lowest AbbVie stock forecast in the analyst group was
$150.0, with a standard deviation of $14.791. Get the latest Zacks research report on ABBV — FREE
Top Analyst Picks of the Dow
The Top 20 Largest U.S. Stocks By Market Cap
| Company Name: |
AbbVie Inc |
| Stock buyback: |
ABBV buyback |
| Website: |
www.abbvie.com |
| Sector: |
Drugs & Pharmaceuticals |
| Number of ETFs Holding ABBV: |
133 |
| Total Market Value Held by ETFs: |
$38.72B |
| Total Market Capitalization: |
$287.15B |
| % of Market Cap. Held by ETFs: |
13.48% |
|
|
May 2, 2024 • 12:02 PM Eastern
Buy (3.17 out of 4)
37th percentile
|
|
Free ABBV Email Alerts:
